6 Firms Guide UK Biotech Startup's $215M SPAC Merger
U.K. biotechnology startup Zura Bio Ltd. said Friday it plans to merge with a special-purpose acquisition company in a deal that could take it public, valued at $215 million and funding...To view the full article, register now.
Already a subscriber? Click here to view full article